412 related articles for article (PubMed ID: 32526342)
1. Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis.
Lamba M; Ngu JH; Stedman CAM
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):573-579.e1. PubMed ID: 32526342
[TBL] [Abstract][Full Text] [Related]
2. The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude.
Webb GJ; Ryan RP; Marshall TP; Hirschfield GM
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2587-2596. PubMed ID: 33493696
[TBL] [Abstract][Full Text] [Related]
3. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.
Boberg KM; Aadland E; Jahnsen J; Raknerud N; Stiris M; Bell H
Scand J Gastroenterol; 1998 Jan; 33(1):99-103. PubMed ID: 9489916
[TBL] [Abstract][Full Text] [Related]
5. A nationwide study of autoimmune liver diseases in the Faroe Islands: Incidence, prevalence, and causes of death 2004 - 2021.
Nielsen KR; Midjord J; Johannesen HL; Grønbæk H
Int J Circumpolar Health; 2023 Dec; 82(1):2221368. PubMed ID: 37300838
[No Abstract] [Full Text] [Related]
6. Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database.
Lim J; Kim HJ
Orphanet J Rare Dis; 2024 Apr; 19(1):178. PubMed ID: 38685058
[TBL] [Abstract][Full Text] [Related]
7. The differences in post-liver transplant outcomes of patients with autoimmune hepatitis who present with overlapping autoimmune liver diseases.
Lee DU; Ponder R; Lee K; Menegas S; Fan GH; Chou H; Jung D; Lee K; Hastie DJ; Urrunaga NH
Hepatol Int; 2023 Jun; 17(3):720-734. PubMed ID: 36575337
[TBL] [Abstract][Full Text] [Related]
8. Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand.
Ngu JH; Gearry RB; Frampton CM; Stedman CA
Hepatology; 2012 Feb; 55(2):522-9. PubMed ID: 21994151
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center.
Nejad SEM; Heiat M; Javanbakht M; Alavian SM; Haris MAA
BMC Gastroenterol; 2024 Jan; 24(1):17. PubMed ID: 38178070
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in clinical practice: epidemiology of autoimmune liver diseases.
Trivedi PJ; Hirschfield GM
Gut; 2021 Oct; 70(10):1989-2003. PubMed ID: 34266966
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta-analysis.
Jensen AH; Winther-Sørensen M; Burisch J; Bergquist A; Ytting H; Gluud LL; Wewer Albrechtsen NJ
Liver Int; 2023 Nov; 43(11):2479-2491. PubMed ID: 37752719
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of autoimmune liver disease.
Feld JJ; Heathcote EJ
J Gastroenterol Hepatol; 2003 Oct; 18(10):1118-28. PubMed ID: 12974897
[TBL] [Abstract][Full Text] [Related]
15. Increased Posttransplant Mortality for Autoimmune Hepatitis Compared With Other Autoimmune Liver Diseases.
Lee JY; Danford CJ; Patwardhan VR; Bonder A
J Clin Gastroenterol; 2020 Aug; 54(7):648-654. PubMed ID: 31651572
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
[TBL] [Abstract][Full Text] [Related]
17. Trends in liver transplantation for autoimmune liver diseases: a Canadian study.
Murillo Perez CF; Ivanics T; Claasen MPAW; Yoon P; Wallace D; Selzner N; Hirschfield GM; Hansen BE; Sapisochin G
Can J Surg; 2022; 65(5):E665-E674. PubMed ID: 36223935
[TBL] [Abstract][Full Text] [Related]
18. [Autoimmune liver diseases].
Fischer HP; Goltz D
Pathologe; 2020 Sep; 41(5):444-456. PubMed ID: 32749523
[TBL] [Abstract][Full Text] [Related]
19. Worldwide Incidence of Autoimmune Liver Disease.
Jepsen P; Grønbæk L; Vilstrup H
Dig Dis; 2015; 33 Suppl 2():2-12. PubMed ID: 26641102
[TBL] [Abstract][Full Text] [Related]
20. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
